Show simple item record

dc.contributor.authorRautenberg, Tamlyn
dc.contributor.authorHall, Peter
dc.description.abstractCollecting clinical efficacy and safety data in multinational randomised controlled trials (MNRCTs) has long been a means to achieve rapid recruitment of sufficient sample sizes in a timely manner. The strengths and weaknesses of this approach have been well explored in the literature. MNRCTs also provide an opportunity to collect health economic evidence, which introduces its own set of challenges. The following editorial provides an overview of special considerations when collecting health economic evidence alongside MNRCTs. It begins with a description of data collection issues at country level, followed by methodological considerations for analysing data, and finally some considerations for the generalisability of results to country-specific reimbursement decisions.
dc.publisherPharma Publications
dc.relation.ispartofjournalJournal for Clinical Studies
dc.subject.fieldofresearchClinical sciences
dc.subject.fieldofresearchApplied economics
dc.subject.fieldofresearchOther economics
dc.titleHealth Economics and Multinational Randomised Controlled Trials
dc.typeJournal article
dcterms.bibliographicCitationRautenberg, T; Hall, P, Health Economics and Multinational Randomised Controlled Trials, Journal for Clinical Studies, 2013, 9 (2), pp. 12-14
gro.hasfulltextNo Full Text
gro.griffith.authorRautenberg, Tamlyn

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record